These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18804387)

  • 61. [Progress in development of influenza virus-like particles].
    Ge SQ; Wang ZL
    Bing Du Xue Bao; 2013 Mar; 29(2):224-32. PubMed ID: 23757857
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
    De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
    Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data.
    Leroux-Roels G
    Expert Opin Biol Ther; 2009 Aug; 9(8):1057-71. PubMed ID: 19555313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells.
    Meghrous J; Khramtsov N; Buckland BC; Cox MM; Palomares LA; Srivastava IK
    Biotechnol Bioeng; 2015 Nov; 112(11):2267-75. PubMed ID: 25943562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mass spectrometry analysis of the influenza virus.
    Downard KM; Morrissey B; Schwahn AB
    Mass Spectrom Rev; 2009; 28(1):35-49. PubMed ID: 18785239
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Progress in vaccine development based on baculovirus expression vector system].
    Rong R; Li T; Zhang Y; Gu Y; Xia N; Li S
    Sheng Wu Gong Cheng Xue Bao; 2019 Apr; 35(4):577-588. PubMed ID: 31001944
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The development and manufacture of influenza vaccines.
    Buckland BC
    Hum Vaccin Immunother; 2015; 11(6):1357-60. PubMed ID: 25844949
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.
    Cox MM; Izikson R; Post P; Dunkle L
    Ther Adv Vaccines; 2015 Jul; 3(4):97-108. PubMed ID: 26478817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Use of affinity purified antibodies for immunoenzyme determination of ovalbumin in influenza virus concentrates and influenza vaccines].
    Kapitanova NA; Khimchenko VP
    Tr Inst Im Pastera; 1988; 64():133-5. PubMed ID: 3077712
    [No Abstract]   [Full Text] [Related]  

  • 70. Application of PCR technology in vaccine product development.
    Wolf JJ; Wang L; Wang F
    Expert Rev Vaccines; 2007 Aug; 6(4):547-58. PubMed ID: 17669009
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Recombinant baculovirus as immunogens].
    Peralta A; Molinari MP; Taboga O
    Rev Argent Microbiol; 2006; 38(2):74. PubMed ID: 17037253
    [No Abstract]   [Full Text] [Related]  

  • 72. Safety assessment of Madin Darby canine kidney cells as vaccine substrate.
    Medema JK; Meijer J; Kersten AJ; Horton R
    Dev Biol (Basel); 2006; 123():243-50; discussion 265-6. PubMed ID: 16566450
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Egg beaters. Flu vaccine makers look beyond the chicken egg.
    Hopkin K
    Sci Am; 2004 Mar; 290(3):16, 18. PubMed ID: 14981872
    [No Abstract]   [Full Text] [Related]  

  • 74. [The latest trend and prospects of development of influenza vaccine].
    Harada Y; Itamura S
    Nihon Rinsho; 2011 Sep; 69(9):1567-70. PubMed ID: 21922754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development.
    Hong Q; Liu J; Wei Y; Wei X
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515034
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Critical phases of viral production processes monitored by capacitance.
    Petiot E; Ansorge S; Rosa-Calatrava M; Kamen A
    J Biotechnol; 2017 Jan; 242():19-29. PubMed ID: 27867077
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Innovations in the Insect Cell Expression System for Industrial Recombinant Vaccine Antigen Production.
    Cox MMJ
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960250
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Biological and immunological properties of influenza virus strain JS/75-29R2T1 (author's transl)].
    Wang GQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jul; 15(4):212-5. PubMed ID: 7333184
    [No Abstract]   [Full Text] [Related]  

  • 79. [Quantitative studies on the chicken protein content in influenza vaccine].
    Gruschkau H; Mauler R; Hennessen W
    Arzneimittelforschung; 1968 Oct; 18(10):1317-9. PubMed ID: 4974421
    [No Abstract]   [Full Text] [Related]  

  • 80. United States Pharmacopeia activities in the area of vaccines, virology and immunology.
    Morris TS
    Vaccine; 2005 Mar; 23(17-18):2311-3. PubMed ID: 15755617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.